Breakthroughs in cancer pose the ‘Who pays?’ question, says Dr Neil Murray, Redx Pharma
Forward thinking: According to Dr Neil Murray, drug discovery and development is key to achieving improvements in cancer diagnosis and treatment
Who is footing the bill for cancer?
Breakthroughs in cancer pose the ‘Who pays?’ question, says Dr Neil Murray, Redx Pharma
Published:
|
3 min read
Last updated:
Sign up to our newsletter
The week's biggest stories from this industry, direct to your inbox.